Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 16.63 INR
Change Today +2.38 / 16.70%
Volume 18.1K
As of 6:10 AM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

medicamen biotech ltd (MDCB) Snapshot

Open
15.69
Previous Close
14.25
Day High
17.10
Day Low
14.20
52 Week High
09/15/14 - 19.25
52 Week Low
05/15/14 - 7.60
Market Cap
148.2M
Average Volume 10 Days
3.6K
EPS TTM
-1.00
Shares Outstanding
8.9M
EX-Date
09/21/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAMEN BIOTECH LTD (MDCB)

Related News

No related news articles were found.

medicamen biotech ltd (MDCB) Related Businessweek News

No Related Businessweek News Found

medicamen biotech ltd (MDCB) Details

Medicamen Biotech Limited manufactures and markets pharmaceutical formulations in India and internationally. It offers its products in various forms, such as tablets, capsules, oral liquid, dry syrups, ointment, and ORS. The company was incorporated in 1993 and is based in Delhi, India.

Founded in 1993

medicamen biotech ltd (MDCB) Top Compensated Officers

Founder, Managing Director, Director and Memb...
Total Annual Compensation: 5.0M
Whole Time Director and Member of Stakeholder...
Total Annual Compensation: 2.3M
Whole-Time Director and Member of Quality Ass...
Total Annual Compensation: 503.2K
Compensation as of Fiscal Year 2014.

medicamen biotech ltd (MDCB) Key Developments

Medicamen Biotech Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Medicamen Biotech Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, net sales/income from operation was INR 128.934 million against INR 120.180 million a year ago. Loss from operation before other income, finance cost and exceptional item was INR 1.157 million against profit from operation before other income, finance cost and exceptional item of INR 1.222 million a year ago. Loss from ordinary activities before tax was INR 4.214 million against INR 5.203 million a year ago. Net loss was INR 3.691 million or INR 0.41 per basic and diluted share against INR 4.274 million or INR 0.50 per basic and diluted share a year ago. For the nine months, net sales/income from operation was INR 592.235 million against INR 508.570 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 13.895 million against INR 25.796 million a year ago. Profit from ordinary activities before tax was INR 3.535 million against INR 6.748 million a year ago. Net profit was INR 4.348 million or INR 0.49 per basic and diluted share against INR 5.380 million or INR 0.63 per basic and diluted share a year ago.

Medicamen Biotech Ltd. to Report Q3, 2015 Results on Feb 14, 2015

Medicamen Biotech Ltd. announced that they will report Q3, 2015 results on Feb 14, 2015

Medicamen Biotech Ltd., Board Meeting, Feb 14, 2015

Medicamen Biotech Ltd., Board Meeting, Feb 14, 2015. Agenda: To discuss and approve unaudited earnings results for the third quarter and nine months ended on December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCB:IN 16.63 INR +2.38

MDCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDCB.
View Industry Companies
 

Industry Analysis

MDCB

Industry Average

Valuation MDCB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.8x
Price/Cash Flow 6.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAMEN BIOTECH LTD, please visit www.medicamen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.